Fintech PR
Manulife Investment Management Publishes Inaugural TNFD Aligned Nature-related Disclosure for Timberland and Agriculture
Milestone report shares the firm’s commitments to a nature-positive future
TORONTO, Jan. 18, 2024 /PRNewswire/ — Manulife Investment Management (Manulife IM) announced it has published its inaugural timberland and agriculture nature disclosure, aligned with the recommendations of the Taskforce on Nature-related Financial Disclosures (TNFD). As an early supporter of TNFD, Manulife IM will be an early adopter with its publication of its TNFD-aligned disclosure. As the world’s largest manager of natural capital, Manulife IM prioritized issuing this report, which outlines its responsible approach to the stewardship of timberland and agricultural assets.1 Manulife IM oversees approximately 5.5 million acres of timberland across the United States, Canada, New Zealand, Australia, Brazil, and Chile and manages approximately 400,000 acres of prime farmland in major agricultural regions of the United States and in Canada, Chile, and Australia. These assets total more than $15 billion as of June 30, 2023, as part of Manulife IM’s comprehensive private markets strategies.
“Although the TNFD is a recent initiative, we have maintained a longstanding commitment to the responsible stewardship of timberland and farmland for over 30 years,” said Brian Kernohan, Chief Sustainability Officer, Private Markets, Manulife Investment Management. “Our first TNFD-aligned nature disclosure marks an important milestone, and it further attests our ongoing pursuit of excellence in responsible operations and transparent reporting as well as our commitment to nature and our support for the TNFD framework.”
The TNFD aims to bring changes to the culture and actions of companies and financial institutions through risk management and mainstream corporate reporting as it relates to nature-related assessment and disclosure. The TNFD recommends 14 disclosures covering governance, strategy, risk and impact management, and metrics and targets, to promote the provision of clear, comparable, and consistent information by companies to investors and other providers of capital. Manulife IM has supported the development of the TNFD since its early stages, championing the release of the TNFD’s final recommendations and reporting framework in September 2023.
“Nature-related dependencies, impacts, risks, and opportunities are thoroughly considered throughout our business, from the initial stages of investment due diligence to the operational management. We believe it’s our responsibility to keep natural capital assets healthy and productive over the long term,” said Thomas Sarno, Global Head of Timberland Investments, Manulife Investment Management. “We strive to proactively assess and manage nature-related risks and opportunities to help our clients achieve their objectives and build resilient portfolios.”
“Nature plays a vital role in the future success of our businesses, the economy, and society,” added Oliver S. Williams IV, Global Head of Agriculture Investments, Manulife Investment Management. “Alignment with the TNFD general requirements and disclosures, with the data and information currently available, is a significant step in our journey to achieving key priorities of our sustainability program supporting climate change mitigation and positive biodiversity and nature-related outcomes.”
Highlights from the report include:
- Materiality in the investment process
- Across both timberland and agriculture, Manulife’s IM’s stewardship approach focuses on climate, nature, and people throughout the cycle of an investment.
- Since 2021, the firm has used a proprietary process—its sustainability tool kit—that was co-developed in house by its sustainability, acquisitions, and operations teams to identify, assess, and score environmental, social, and governance components of every transaction.
- Together with its deforestation policy, carbon principles, and carbon tool kit (used specifically for forest carbon project evaluation) this approach is designed to systematically consider all identified material sustainability considerations.
- Materiality in operations
- Manulife IM believes independent third-party sustainability certification is a comprehensive mechanism for credibly demonstrating sustainable asset management and, critically, that it provides independent assurance to stakeholders.
- As of December 31, 2022, 100% of Manulife IM’s managed forests were certified under either the Sustainable Forestry Initiative® (SFI) or Forest Stewardship Council® (FSC).2 In agriculture, 100% of its U.S. farmland investments were certified in June 2022 to the Leading Harvest Farmland Management Standard by a third party,3 and other agriculture investments have participated in Leading Harvest pilot programs in Australia and Canada. Some assets have been certified to additional agriculture standards on a case-by-case basis. Overall, 223 of the 245 properties (91%, or approximately 80% of agriculture assets under management) in the global agriculture investment portfolio carried one or more third-party certifications.
- Consideration of time horizons
- Long-term thinking is fundamental to timberland and agriculture investment management and Manulife IM’s experience operating timberland and farmland assets over the past 30 years has shaped and refined its ability to manage sustainably over extended time horizons.
- Manulife IM’s financial models and asset management plans are forecast over 50 years for timberland, while for agriculture the forecast is typically 10 to 30 years ahead, depending on the type of asset.
|
1 IPE research, as of February 5, 2023. Ranking is based on total natural capital assets under management (AUM), which includes forestry/timberland and agriculture/farmland AUM. Firms were asked to provide AUM and the as of dates vary from December 31, 2021, to December 31, 2022. |
|
2 As of December 31, 2022, 100% of our forests were certified under either SFI (3.2 million acres in the United States and Canada) or FSC (2.2 million acres in Australia, New Zealand, Brazil, and Chile). |
|
3 Certification as of June 2022, by Leading Harvest and is based on an annual assessment of the conformation to the Farmland Management Standard. Manulife Investment Management’s timberland and agriculture team (then operating as Hancock Natural Resource Group) is a founding member of Leading Harvest. In addition, Oliver Williams, global head of agriculture, is current chair of the Board of Directors for Leading Harvest. For more information on Leading Harvest, please see leadingharvest.org/about. |
About Manulife Investment Management
Manulife Investment Management is the brand for the global wealth and asset management segment of Manulife Financial Corporation. Our mission is to make decisions easier and lives better by empowering investors for a better tomorrow. Serving more than 17 million individuals, institutions, and retirement plan members, we believe our global reach, complementary businesses, and the strength of our parent company position us to help investors capitalize on today’s emerging global trends. We provide our clients access to public and private investment solutions across equities, fixed income, multi-asset, alternative, and sustainability-linked strategies, such as natural capital, to help them make more informed financial decisions and achieve their investment objectives. Not all offerings are available in all jurisdictions. For additional information, please visit manulifeim.com.
Media Contact: Elizabeth Bartlett, Elizabeth_Bartlett@Manulife.com
View original content:https://www.prnewswire.co.uk/news-releases/manulife-investment-management-publishes-inaugural-tnfd-aligned-nature-related-disclosure-for-timberland-and-agriculture-302038456.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
Letter from Gatemore Capital Management LLP to Elementis PLC
-
Latest News4 days ago
Shanghai Electric Releases ESG Report, Highlighting Sustainable Development Achievements in 2023
-
Latest News4 days ago
Hyosung Heavy Industries Ranked on BNEF’s Energy Storage Tier 1 List
-
Latest News7 days ago
Former Tesla executive Tim Newell is set to spin off Aspiration’s consumer financial services division.
-
Latest News4 days ago
Talino, Chemonics invest in startup Higala, the Philippines’ pioneering inclusive instant payment system
-
Latest News7 days ago
United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52%
-
Latest News3 days ago
SAR1.1 Billion Riyadh Real Estate Fund Launched by Ezdihar Real Estate Development & Al-Istithmar Capital
-
Latest News7 days ago
Morgan Stanley B.V. – annual report and financial statements for the financial year ended 31 December 2023